RN7SL165P

Across TCGA pan-cancer cohorts, RN7SL165P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RN7SL165P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RN7SL165P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RN7SL165P expression acts as an unfavorable survival marker, although some lineages such as BRCA and CHOL show a favorable association.

BRCA, CHOL, and COAD are the cancer types where RN7SL165P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	All	0.968	0.939	.003	38	view →
CHOL	DFS	Quartile	All	0.784	0.275	.010	25	view →
COAD	OS	Tertile	III,IV	0.235	0.618	.006	18	view →
GBM	DFS	Median	All	0.159	0.382	<.001	15	view →
LUSC	DFS	Tertile	All	0.724	0.614	.016	15	view →
THYM	DFS	Tertile	IV	0.407	1.000	.026	15	view →
PRAD	DFS	Quartile	All	0.818	0.905	.010	14	view →
KIRP	OS	Quartile	II,III,IV	0.179	0.710	.006	12	view →
OV	DFS	Tertile	IV	0.352	0.530	.023	12	view →
READ	OS	Tertile	IV	0.077	1.000	.014	12	view →
KIRC	DFS	Quartile	IV	0.342	0.643	.010	10	view →
LGG	DFS	Quartile	All	0.279	0.455	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RN7SL165P–BRCA (DFS)

Open the BRCA breakdown →